RNA testing can reliably identify the virus, but it is not covered by health insurance in Japan; it is more practical to follow‐up with blood tests for liver dysfunction and HEV IgA to determine whether acute hepatitis or liver failure develops. Here, CD79A is linked to Hepatic failure.